The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of bridging therapy (BT) on outcome of relapsed refractory multiple myeloma (RRMM) with Ide-cel CAR T-cell therapy: Real-world experience from the US myeloma CAR T consortium.
 
Aimaz Afrough
No Relationships to Disclose
 
Hamza Hashmi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Sanofi
 
Doris K. Hansen
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Bristol-Myers Squibb/Celgene
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Chul Ahn
Leadership - Psomagen
Stock and Other Ownership Interests - Psomagen
Consulting or Advisory Role - Advarra; Chong Kun Dang Pharmaceutical; IQVIA; LSK Global; PPD Global; Syneos Health
Speakers' Bureau - LSK Global
 
Danai Dima
No Relationships to Disclose
 
Ciara L. Freeman
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Incyte; Janssen Biotech; ONK Therapeutics; Sanofi; Seagen
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Incyte; ONK Therapeutics; Sanofi; Seagen
Research Funding - Bristol-Myers Squibb; Janssen Biotech; Roche/Genentech
 
Omar Alexis Castaneda Puglianini
Speakers' Bureau - Adaptive Biotechnologies
 
Mehmet H. Kocoglu
Research Funding - Abbvie/Genentech (Inst); BMS (Inst); Genentech (Inst); GlaxoSmithKline (Inst); janssen (Inst); Poseida (Inst)
 
Shebli Atrash
Honoraria - Janssen
Research Funding - Amgen; Celgene/Bristol-Myers Squibb (Inst); GlaxoSmithKline; Janssen Oncology (Inst); Karyopharm Therapeutics
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Leyla Shune
No Relationships to Disclose
 
Gary Simmons
Speakers' Bureau - Kite, a Gilead company
 
Douglas W. Sborov
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Legend Biotech; Pfizer; Sanofi; Skyline Diagnostics
 
Christopher J. Ferreri
Stock and Other Ownership Interests - Affimed Therapeutics
Consulting or Advisory Role - Sanofi
 
Charlotte Burton Wagner
Employment - Abbvie (I)
Consulting or Advisory Role - Pfizer
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Poseida; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jack Khouri
No Relationships to Disclose
 
Larry D. Anderson, Jr
Honoraria - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Cellectar; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides; Prothena
Consulting or Advisory Role - Abbvie; amgen; BeiGene; Bristol-Myers Squibb/Celgene; Cellectar; GlaxoSmithKline; janssen; Karyopharm Therapeutics; Oncopeptides; Prothena
Research Funding - amgen; bms; celgene; GlaxoSmithKline; janssen; Karyopharm Therapeutics
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Pfizer (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)